Friday, June 19, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

India’s pandemic surge turns political

Outside an upscale Indian hospital last week, Baljeet Asthana put her phone on selfie mode, propped her eyeglasses on her head so she could stare directly into the camera, and hit record.

Through a white polka-dot mask, she described her family’s ordeal: Her 82-year-old mother was inside the hospital “struggling for her life,” Asthana said. Her mother desperately needed an intensive care unit bed, but the hospital — Fortis Hospital, one of the best-equipped private facilities in the capital, New Delhi — was full. Officials told the family to look for an ICU bed elsewhere.

“My mother is slowly dying,” reads her tweet accompanying her video.

Source: NPR

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!